Antigen Binding Constructs
The present invention is directed to antigen binding constructs comprising one or two epitope binding domains separated by a single chain Fc region of an antibody, wherein each epitope binding domain in capable of binding to VEGF, to dimers comprising two antigen binding constructs of the invention,...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Hughes-Thomas Zoe Lewis Alan Peter Steward Michael ASHMAN Claire Catchpole Ian Richard |
description | The present invention is directed to antigen binding constructs comprising one or two epitope binding domains separated by a single chain Fc region of an antibody, wherein each epitope binding domain in capable of binding to VEGF, to dimers comprising two antigen binding constructs of the invention, pharmaceutical compositions comprising said dimers and their use in the treatment of diseases associated with VEGF signalling, such as diabetic macular edema (DME), wet age-related macular degeneration (Wet AMD), diabetic retinopathy, retinal vein occlusion (RVO), and corneal neovascularisation, and polynucleotide sequences encoding said antigen binding constructs. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2017029494A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2017029494A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2017029494A13</originalsourceid><addsrcrecordid>eNrjZJByzCvJTE_NU3DKzEvJzEtXcM7PKy4pKk0uKeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGhuYGRpYmliaOhsbEqQIA0Z0j-g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Antigen Binding Constructs</title><source>esp@cenet</source><creator>Hughes-Thomas Zoe ; Lewis Alan Peter ; Steward Michael ; ASHMAN Claire ; Catchpole Ian Richard</creator><creatorcontrib>Hughes-Thomas Zoe ; Lewis Alan Peter ; Steward Michael ; ASHMAN Claire ; Catchpole Ian Richard</creatorcontrib><description>The present invention is directed to antigen binding constructs comprising one or two epitope binding domains separated by a single chain Fc region of an antibody, wherein each epitope binding domain in capable of binding to VEGF, to dimers comprising two antigen binding constructs of the invention, pharmaceutical compositions comprising said dimers and their use in the treatment of diseases associated with VEGF signalling, such as diabetic macular edema (DME), wet age-related macular degeneration (Wet AMD), diabetic retinopathy, retinal vein occlusion (RVO), and corneal neovascularisation, and polynucleotide sequences encoding said antigen binding constructs.</description><language>eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170202&DB=EPODOC&CC=US&NR=2017029494A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170202&DB=EPODOC&CC=US&NR=2017029494A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Hughes-Thomas Zoe</creatorcontrib><creatorcontrib>Lewis Alan Peter</creatorcontrib><creatorcontrib>Steward Michael</creatorcontrib><creatorcontrib>ASHMAN Claire</creatorcontrib><creatorcontrib>Catchpole Ian Richard</creatorcontrib><title>Antigen Binding Constructs</title><description>The present invention is directed to antigen binding constructs comprising one or two epitope binding domains separated by a single chain Fc region of an antibody, wherein each epitope binding domain in capable of binding to VEGF, to dimers comprising two antigen binding constructs of the invention, pharmaceutical compositions comprising said dimers and their use in the treatment of diseases associated with VEGF signalling, such as diabetic macular edema (DME), wet age-related macular degeneration (Wet AMD), diabetic retinopathy, retinal vein occlusion (RVO), and corneal neovascularisation, and polynucleotide sequences encoding said antigen binding constructs.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJByzCvJTE_NU3DKzEvJzEtXcM7PKy4pKk0uKeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGhuYGRpYmliaOhsbEqQIA0Z0j-g</recordid><startdate>20170202</startdate><enddate>20170202</enddate><creator>Hughes-Thomas Zoe</creator><creator>Lewis Alan Peter</creator><creator>Steward Michael</creator><creator>ASHMAN Claire</creator><creator>Catchpole Ian Richard</creator><scope>EVB</scope></search><sort><creationdate>20170202</creationdate><title>Antigen Binding Constructs</title><author>Hughes-Thomas Zoe ; Lewis Alan Peter ; Steward Michael ; ASHMAN Claire ; Catchpole Ian Richard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2017029494A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>Hughes-Thomas Zoe</creatorcontrib><creatorcontrib>Lewis Alan Peter</creatorcontrib><creatorcontrib>Steward Michael</creatorcontrib><creatorcontrib>ASHMAN Claire</creatorcontrib><creatorcontrib>Catchpole Ian Richard</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Hughes-Thomas Zoe</au><au>Lewis Alan Peter</au><au>Steward Michael</au><au>ASHMAN Claire</au><au>Catchpole Ian Richard</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Antigen Binding Constructs</title><date>2017-02-02</date><risdate>2017</risdate><abstract>The present invention is directed to antigen binding constructs comprising one or two epitope binding domains separated by a single chain Fc region of an antibody, wherein each epitope binding domain in capable of binding to VEGF, to dimers comprising two antigen binding constructs of the invention, pharmaceutical compositions comprising said dimers and their use in the treatment of diseases associated with VEGF signalling, such as diabetic macular edema (DME), wet age-related macular degeneration (Wet AMD), diabetic retinopathy, retinal vein occlusion (RVO), and corneal neovascularisation, and polynucleotide sequences encoding said antigen binding constructs.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2017029494A1 |
source | esp@cenet |
subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
title | Antigen Binding Constructs |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T13%3A27%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Hughes-Thomas%20Zoe&rft.date=2017-02-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2017029494A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |